menu
    • menu

    Company profile for LSL Pharma Group

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LSL Pharma Group inc. comes from a long-term vision, a desire for expansion driven by the desire to further develop our expertise and thus offer a diversified range of health products to our customers. The company's listing on the Toronto Venture Exchange (TSXV) represents one more step towards achieving this. Our two manufacturing plants for pharmaceutical products (Steri-Med Pharma inc.) and natural health products (Laborato...
    LSL Pharma Group inc. comes from a long-term vision, a desire for expansion driven by the desire to further develop our expertise and thus offer a diversified range of health products to our customers. The company's listing on the Toronto Venture Exchange (TSXV) represents one more step towards achieving this. Our two manufacturing plants for pharmaceutical products (Steri-Med Pharma inc.) and natural health products (Laboratoire LSL inc.) are constantly evolving to enable us to achieve our growth objectives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LSL Pharma GroupCanada Flag
    Country
    Country
    Canada
    Address
    Address
    540, rue d’Avaugour, Suite 1800 Boucherville (Quebec) J4B 0G6
    Telephone
    Telephone
    +1 5146647700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.groupelslpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LSL Pharma Closes Second Tranche Of Private Placement And Units For Debt
    LSL Pharma Closes Second Tranche Of Private Placement And Units For Debt

    15 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/15/2912939/0/en/LSL-Pharma-Group-Announces-Closing-of-Second-and-Final-Tranche-of-Private-Placement-and-Closing-of-Units-for-Debt.html

    GLOBENEWSWIRE
    15 Jul 2024
    Share Share
    LSL Pharma Group Announces Voting Results Of Annual and Meeting Of Shareholders
    LSL Pharma Group Announces Voting Results Of Annual and Meeting Of Shareholders

    28 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/28/2906175/0/en/LSL-Pharma-Group-Announces-Voting-Results-of-Its-Annual-and-Special-Meeting-of-Shareholders.html

    GLOBENEWSWIRE
    28 Jun 2024
    Share Share
    LSL Secures $1.5 Million as First Closing of Its Non-Brokered Private Placement
    LSL Secures $1.5 Million as First Closing of Its Non-Brokered Private Placement

    27 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/27/2905357/0/en/LSL-Pharma-Group-Secures-1-5-Million-as-the-First-Closing-of-Its-Non-Brokered-Private-Placement.html

    GLOBENEWSWIRE
    27 Jun 2024
    Share Share
    LSL Pharma Completes Acquisition Of Virage Santé
    LSL Pharma Completes Acquisition Of Virage Santé

    18 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/18/2900262/0/en/LSL-Pharma-Group-Completes-the-Acquisition-of-Virage-Sant%C3%A9.html

    GLOBENEWSWIRE
    18 Jun 2024
    Share Share
    LSL Pharma Group Announces Engagement of Red Cloud Securities
    LSL Pharma Group Announces Engagement of Red Cloud Securities

    11 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/11/2896651/0/en/LSL-Pharma-Group-Announces-Engagement-of-Red-Cloud-Securities.html

    GLOBENEWSWIRE
    11 Jun 2024
    Share Share
    SCHOTT, KORU: Collaboration For Large Volume Subcutaneous Infusions
    SCHOTT, KORU: Collaboration For Large Volume Subcutaneous Infusions

    05 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/05/2893730/0/en/LSL-Pharma-Group-Announces-a-Combination-of-Private-Placements-for-Maximum-Aggregate-Gross-Proceeds-of-4-5-Million.html

    GLOBENEWSWIRE
    05 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search